Welcome to our dedicated page for Keurig Dr Pepper SEC filings (Ticker: KDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Keurig Dr Pepper Inc.'s SEC filings document operating results, governance, material events, and capital-structure matters for its beverage and coffee businesses. Form 8-K reports include quarterly and full-year financial results, outlook updates, material agreements, completed acquisition-related events, and other current-report disclosures tied to the company's refreshment beverage portfolio and Keurig coffee platform.
Proxy filings describe shareholder voting matters, board governance, executive compensation, and annual meeting proposals. The filing record also covers security-structure and capital disclosures, risk and financial reporting topics, and governance changes relevant to a public operating company with owned, licensed, and partner beverage and coffee brands.
Keurig Dr Pepper (KDP) Chief Human Resources Officer Mary Beth DeNooyer has sold 12,000 shares of common stock at a weighted average price of $33.64 per share on June 20, 2025. The transaction was executed through a pre-established Rule 10b5-1 trading plan adopted on November 1, 2024.
The sale prices ranged from $33.32 to $33.86 per share. Following the transaction, DeNooyer continues to hold 106,511 shares directly. The Rule 10b5-1 trading plan provides an affirmative defense against insider trading allegations by establishing predetermined trading parameters.
- Transaction value: Approximately $403,680
- Trading plan established: November 1, 2024
- Form 4 filed: June 24, 2025
- Ownership: Direct holding
Keurig Dr Pepper Inc. (Nasdaq: KDP) used a Regulation FD presentation on 23–24 June 2025 to reaffirm its previously issued full-year 2025 outlook. Management reiterated two key non-GAAP targets:
- Constant-currency net sales: expected to rise in the mid-single-digit percentage range versus 2024.
- Adjusted diluted EPS: projected to expand in the high-single-digit percentage range.
No changes were made to the guidance originally communicated earlier in the year, signalling that current trading conditions and cost assumptions remain intact despite ongoing macroeconomic uncertainties. The filing contains standard cautionary language about forward-looking statements and highlights that reconciliations to GAAP metrics are not provided because mark-to-market and other uncontrollable items cannot be reasonably estimated.
The 8-K is furnished under Item 7.01 and therefore is not deemed "filed" for liability purposes under Section 18 of the Exchange Act. No other operational updates, financial tables, acquisitions, or management changes were disclosed.
Keurig Dr Pepper held its Annual Meeting of Stockholders on June 18, 2025, where shareholders voted on three key proposals:
1. Board Elections: All nine director nominees were successfully elected with strong majority support. Notable directors include Timothy Cofer (1.22B votes for), Robert Gamgort (1.21B votes for), and Pamela Patsley (1.17B votes for).
2. Say-on-Pay Vote: Shareholders approved the advisory resolution on executive compensation with 1.15 billion votes in favor (94.5% approval) versus 67.1 million against.
3. Auditor Ratification: Deloitte & Touche LLP was confirmed as the independent auditor for FY2025, receiving overwhelming support with 1.24 billion votes in favor (99.7% approval).
The high approval rates across all proposals indicate strong shareholder confidence in KDP's governance and management. The meeting had significant participation with over 1.2 billion shares voted.
Form 144 Notice filed for Keurig Dr Pepper (KDP) indicates insider Mary Beth Denooyer's proposed sale of 36,000 shares of common stock with an aggregate market value of $1,195,560 through J.P. Morgan Securities. The sale is scheduled for June 20, 2025, on NASDAQ.
The securities to be sold were acquired through multiple transactions:
- Two RSU vestings in March 2024 totaling 12,746 shares
- Five open market purchases between August-December 2019 totaling 23,254 shares
Recent trading history shows Denooyer has sold 60,000 shares in the past 3 months through five separate transactions between April-June 2025, generating approximately $2.05 million in gross proceeds. The average selling price across these transactions was around $34.21 per share.